stockrowLeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.
- Revenue
- +11.3%
- EPS
- −14.3%
- Free cash flow
- −25.8%
- Total debt
- +0.53%
Quarter to September 2026, against a year earlier
Follow LMAT
Alert me
LeMaitre Vascular, Inc. (LMAT) Book value per share
LeMaitre Vascular, Inc.'s book value per share at the end of fiscal 2025 was 17.4×, up 15.7% from 15.0× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 18.9×. Over the past ten years it has ranged from 4.4× (fiscal 2015) to 17.4× (fiscal 2025) — the current reading is the highest in ten years. LeMaitre Vascular, Inc. ranks 18th of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 17.4× | 15.71% |
| FY2024 | 15.0× | 12.04% |
| FY2023 | 13.4× | 9.86% |
| FY2022 | 12.2× | 1.60% |
| FY2021 | 12.0× | 40.93% |
| FY2020 | 8.5× | 14.00% |
| FY2019 | 7.5× | 11.53% |
| FY2018 | 6.7× | 15.80% |
| FY2017 | 5.8× | 22.30% |
| FY2016 | 4.7× | 7.96% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 18.9× | 2.75% |
| Jun 2026 | 18.4× | 3.12% |
| Mar 2026 | 17.8× | 2.59% |
| Dec 2025 | 17.4× | 3.95% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| AZTA Azenta, Inc. compare | 33.3× |
| LMAT LeMaitre Vascular, Inc. | 18.9× |
| ATRC AtriCure, Inc. compare | 10.9× |
| STAA STAAR Surgical Company compare | 7.4× |
| XRAY DENTSPLY SIRONA Inc. compare | 6.8× |
| STVN Stevanato Group S.p.A. compare | 6.7× |
| KMTS Kestra Medical Technologies, Ltd. compare | 3.8× |
| WRBY Warby Parker Inc. compare | 3.2× |
| PLSE Pulse Biosciences, Inc compare | 2.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on LMAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement